Sign in | About Us | Contact Us

Product CAS# Supplier

Sign in | Join free | Shopping Online | Product Index | Buy,Sell (New)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

0

1

2

3

4

5

6

7

8

9

美国FDA的委员会同意Asteilas / Cardiome的心律失常药 Vernakalan        GSK Submits TYVERB(R)/TYKERB(R) (lapatinib) for First-Line Treatment of Metastatic...        临床研究证明: 达沙替尼(Dasatinib/Sprycel)治疗白血病是一种安全有效药物        Zilmax (Zilpaterol hydrochloride) Offers Extended Marketing Window For Cattle Feeders        FDA Approves Gleevec (Imatinib mesylate) to Prevent Recurrence of Rare Gastrointestinal Cancer        2009年国际一线药企重点研发产品时间表        FDA Approves Gleevec (Imatinib mesylate) for Gastrointestinal Stromal Tumor        FDA Approved Drugs During 2008        新药物或可增强甲磺酸伊马替尼抗白血病效果 (Potential New Way To Make A Good Anti-leukemia Drug Imatinib mesylate Even Better)        两部门通知: 11月1日起将提高部分商品出口退税率        WuXi misses Q3 goals due to “drop in R&D spending”        A Report on Brazil's Pharmaceuticals and Healthcare Market for Q3 2008 - Examine the Opportunities in One of the Largest & Most Dynamic Markets in the World        Lilly and Jubilant team up in drug development JV        Piramal expands contract services and research        Zentiva board accepts Sanofi's revised €1.8bn offer        Novartis/Schering AG To Introduce Vatalanib For The Second-line Treatment Of Patients With Metastatic Colorectal Cancer        Brazil, Gilead agree AIDS drug price cut        FDA blocks imports from two Ranbaxy plants        Acquisition looming in Calyx Pharma's future, says CEO        Brazil Rejects Patent On An Essential AIDS Medicine        "Shelved" Antihistamine Shows Promise in Alzheimer's Disease        「退役的」抗组织胺 Dimebon 看似对阿兹海默氏症有效        未Gleevec(imatinib mesylate) Receives FDA Priority Review As First Therapy To Reduce Recurrence Of Gastrointestinal Stromal Tumors After Surgery        Brazil rejects Gilead patent for HIV/AIDS drug Viread (Tenofovir DF)        International Organizations and Foreign Government Agencies for Food Drug Administratation        Thai Government Deals Patent Blow to Big Pharma’s Cancer Drug Monopoly        Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics        Roche vs Cipla: Will the Real Price of "Tarceva" Please Show Up?        FDA MedWatch - July 2008 Drug Safety-Related Labeling Changes for 35 Drugs Now Available on Web        Sutent® Provides Superior Quality of Life Compared with Interferon in Kidney Cancer

苏ICP备05037505号

Copyright 2007 © ChemLink & ChemicalInfo & Pharm-ChemNet & Chinapharm-Chemnet . All rights reserved.  Power By 常州网络公司